Definition & Pathophysiology

  • Reentrant supraventricular tachycardia (SVT) utilizing two functional pathways within atrioventricular (AV) node.
  • Dual AV Nodal Physiology: Requires electrophysiologically distinct pathways.
    • Slow Pathway: Short refractory period. Extends from AV node inferiorly toward coronary sinus ostium.
    • Fast Pathway: Longer refractory period. Located higher on atrial septum, extending laterally away from AV node.
  • “Slow-Fast” (Typical) AVNRT Mechanism: Premature atrial beat encounters refractory fast pathway. Conduction shifts to slow pathway. Electrical impulse returns retrograde to atrium via fast pathway, establishing reentrant circuit. Represents 80–90% of AVNRT cases.
  • Lacks clear anatomic correlates for functional pathways.

Epidemiology

  • Dual AV nodal pathways present in ~30% of general population.
  • Rare in infancy. Incidence increases during childhood and adolescence.
  • More common in adolescents, young adults, and females.
  • Occurs in structurally normal hearts and congenital heart disease (CHD).
  • Found in adults with CHD at same frequency as general population; often identified during electrophysiology (EP) study as secondary arrhythmia.

Clinical Manifestations

  • Abrupt onset and termination.
  • Often triggered by exercise or stress.
  • Symptoms: Palpitations, dizziness, shortness of breath, chest pain.
  • Syncope: Occasional presentation.
  • No increased risk of sudden cardiac death (lacks manifest accessory pathway).

Electrocardiographic (ECG) Features

  • Regular, narrow QRS complex tachycardia.
  • Rate: 150–250 beats/min in children and young adults.
  • P-wave Morphology: Retrograde P waves. Negative axis in inferior leads (II, III, aVF).
  • P-wave Location: Short RP interval. P wave often buried within or immediately following QRS complex.
  • V1 Morphology: Subtle RSr’ pattern (pseudo-R’ wave) visible during tachycardia, absent during normal sinus rhythm.
  • Ventriculoatrial (VA) Interval: <70 ms.

Differential Diagnosis

TachycardiaP-Wave / AV RelationshipResponse to Adenosine
AVNRTBuried/Short RP (VA <70 ms)Sudden termination (P-wave often last component)
AVRT (Orthodromic)Inverted (inferior leads); VA >70 msSudden termination (P-wave typically last component)
Ectopic Atrial TachycardiaAbnormal P-wave axis; Warm-up/Cool-downTransient AV block unmasking ectopic P-waves, or termination
Junctional Ectopic TachycardiaAV dissociation commonTransient VA dissociation; tachycardia continues
Atrial FlutterSaw-tooth waves; 2:1 or 3:1 conductionTransient AV block unmasking flutter waves

Management

Acute Management

  • Hemodynamic stability dictates initial intervention.
ModalityIndication / DosageNuances & Adverse Effects
Vagal ManeuversFirst-line (stable)Ice bag to face (15-30s) in infants. Valsalva, straining, head-stand in older children. Ocular pressure contraindicated. Carotid massage rarely effective.
AdenosineDrug of choice (stable)Rapid IV push: 0.1 mg/kg (max 6 mg). May increase to 0.2 mg/kg (max 12 mg). Requires continuous ECG and immediate direct current (DC) cardioversion availability (risk of inducing atrial fibrillation).
Calcium Channel BlockersAlternative (older children)Verapamil reduces cardiac output. Contraindicated in infants <1 year (causes severe hypotension/cardiac arrest).
DC CardioversionHemodynamic instabilitySynchronized shock: 0.5–2 J/kg.
Esophageal PacingAlternative terminationPace termination using esophageal catheter.

Chronic & Definitive Management

  • Medical Therapy: -blockers represent drugs of choice for chronic suppression. Calcium channel blockers also utilized safely.
  • Catheter Ablation:
    • Class IIa indication per PACES/HRS guidelines.
    • Definitive cure in >95% of patients.
    • Target: Slow pathway modification.
    • Risk: Unintended damage to fast pathway causing complete AV block, necessitating permanent pacemaker implantation.
    • Energy Source: Radiofrequency ablation or cryoablation. Cryoablation preferred near AV node; no permanent AV block reported with this energy source.

Nuances in Congenital Heart Disease (ACHD)

  • AV node location highly variable in specific congenital lesions.
  • High-Risk Anatomy: Atrioventricular septal defects (AVSD) and congenitally corrected transposition of the great arteries (L-TGA) feature displaced AV nodal conduction tissue.
  • Single ventricle anatomy severely complicates mapping and ablation procedures.
  • Medical management preferred over ablation in complex CHD variants due to high risk of inadvertent AV node injury and heart block.